Results 241 to 250 of about 95,889 (290)

Treatment‐Refractory Tracheobronchitis in Crohn's Disease: A Rare Pulmonary Manifestation of Inflammatory Bowel Disease

open access: yesRespirology Case Reports, Volume 13, Issue 10, October 2025.
In this report, we present a case of tracheobronchitis in Crohn's disease presenting with a chronic productive cough while on infliximab. The diagnosis was made on bronchoscopy, which revealed inflammation of the trachea and main bronchi, with biopsies demonstrating squamous cell metaplasia consistent with pulmonary inflammatory bowel disease ...
Gabriel Gurieff   +4 more
wiley   +1 more source

Predictive Analysis for First Submission of Generic Drug Application for Orphan Drug Products Using Random Survival Forest

open access: yesClinical and Translational Science, Volume 18, Issue 10, October 2025.
ABSTRACT Rare diseases affect a small population of patients, resulting in low incentives for developing orphan drug products (ODPs). The United States Congress passed the Orphan Drug Act of 1983 to incentivize pharmaceutical manufacturers to develop drugs to treat rare diseases.
Robert Hopefl   +6 more
wiley   +1 more source

A real-world study based on the FAERS database evaluating adverse drug reactions in three amphotericin B lipid formulations. [PDF]

open access: yesJ Pharm Policy Pract
Tong B   +10 more
europepmc   +1 more source

Review of experimental equine synovitis models for inducing lameness

open access: yesEquine Veterinary Education, Volume 37, Issue 10, Page 547-560, October 2025.
Summary Lameness in horses, particularly in relation to osteoarthritis (OA), is complex and variable, highlighting the importance of experimental models in advancing our understanding of pain and lameness. Synovitis plays a critical role in the development of OA, and reversible models of synovitis offer valuable insights into physiology and potential ...
A. Dockery, B. Beasley, V. J. Moorman
wiley   +1 more source

Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology‐Driven Delivery Strategies

open access: yesFundamental &Clinical Pharmacology, Volume 39, Issue 5, October 2025.
ABSTRACT This review highlights the integration of drug repurposing and nanotechnology‐driven delivery strategies as innovative approaches to enhance the antifungal activity of statins against mucosal candidiasis, providing a framework for future translational research and clinical application.
Dominique Mesquita e Silva   +8 more
wiley   +1 more source

Activation of G protein‐coupled parathyroid hormone receptors in rat incisor odontoblasts promotes mineralization via cyclic adenosine monophosphate, not Ca2+ signalling: In vitro study

open access: yesInternational Endodontic Journal, Volume 58, Issue 10, Page 1616-1628, October 2025.
Abstract Aim Parathyroid hormone (PTH) and its Gαs‐coupled receptors, PTH receptor, mediate odontoblast differentiation; however, the detailed intracellular adenylyl cyclase‐mediated signalling pathway mediated by the PTH–PTH receptor axis remains to be elucidated. Therefore, we measured the intracellular levels of cyclic adenosine monophosphate (cAMP)
Natsuki Saito   +4 more
wiley   +1 more source

Genome alteration of Leishmania orientalis under Amphotericin B inhibiting conditions. [PDF]

open access: yesPLoS Negl Trop Dis
Anuntasomboon P   +7 more
europepmc   +1 more source

UV‐A Radiation Impairs Sebaceous‐Gland‐Related Skin Barrier Function by Inducing Inflammation and Altering Intracellular Sebum‐Like Lipid Composition

open access: yesJournal of Cosmetic Dermatology, Volume 24, Issue 10, October 2025.
ABSTRACT Background Sebaceous glands (SGs) secrete sebum to form a protective barrier that maintains skin health. However, exposure to ultraviolet A (UV‐A) radiation damages the skin barrier, leading to dryness and inflammation. Aims In this study, we investigated how UV‐A radiation alters SG function, focusing on inflammation and changes in the ...
Wangyue Dong   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy